Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01582763 · ClinicalTrials.gov registry record
International Guillain-Barré Syndrome Outcome Study
A clinical trial, sponsored by Erasmus Medical Center.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT01582763 is a clinical trial that has completed, run by Erasmus Medical Center. The registered enrollment target is 2,000 participants.
The verdict
NCT01582763 has completed, sponsored by Erasmus Medical Center.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2012-05-01 |
| Est. Completion | 2024-12-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01582763
The ClinicalTrials.gov registry entry for NCT01582763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erasmus Medical Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01582763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01582763 about?
NCT01582763 is a clinical study titled "International Guillain-Barré Syndrome Outcome Study". International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors...
What is the current status of trial NCT01582763?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2012-05-01. Estimated completion is 2024-12-02.
Who is sponsoring clinical trial NCT01582763?
This trial is sponsored by Erasmus Medical Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.